[Research advance of ANRIL on atherosclerosis by regulating cell proliferation and apoptosis]

Juan Fang1, Zhicheng Pan1, Xiaogang Guo1

  • 1Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

Insights

The long non-coding RNA ANRIL, a key factor in atherosclerosis, regulates vascular cell proliferation and apoptosis through its linear and circular transcripts. Understanding ANRIL

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Research

Background:

  • Atherosclerosis is a primary cause of coronary artery disease.
  • The Chr9p21 locus, containing the ANRIL gene, is strongly linked to atherosclerosis risk.
  • ANRIL produces diverse transcripts, including linear and circular forms, influencing vascular cell behavior.

Purpose of the Study:

  • To review the evolution and transcript characteristics of ANRIL.
  • To elucidate the roles of ANRIL transcripts in vascular cell proliferation and apoptosis.
  • To explore ANRIL's contribution to atherosclerosis pathogenesis for potential therapeutic targets.

Main Methods:

  • Literature review of ANRIL research.
  • Analysis of ANRIL's molecular mechanisms.
  • Examination of ANRIL's impact on vascular cells (VSMCs and macrophages).

Main Results:

  • ANRIL transcripts, both linear and circular, modulate vascular smooth muscle cell (VSMC) and macrophage proliferation and apoptosis.
  • Linear ANRIL influences VSMC proliferation via chromatin modification and macrophage apoptosis post-transcriptionally.
  • Circular ANRIL impacts VSMC proliferation and rRNA maturation.

Conclusions:

  • ANRIL plays a critical role in atherosclerosis by regulating vascular cell dynamics.
  • Distinct ANRIL transcripts exert varied effects on cellular processes relevant to atherosclerosis.
  • Further understanding of ANRIL is crucial for developing diagnostic and therapeutic strategies for atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
255
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
608
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
247